Whitnell & Co. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.

Quarter-by-quarter ownership
Whitnell & Co. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2019$18,000
-5.3%
2000.0%0.01%0.0%
Q1 2019$19,000
+11.8%
2000.0%0.01%
-12.5%
Q4 2018$17,000
-81.9%
200
-81.7%
0.01%
-78.4%
Q3 2018$94,000
+4.4%
1,095
-8.3%
0.04%0.0%
Q2 2018$90,000
-7.2%
1,1940.0%0.04%
-9.8%
Q1 2018$97,000
-3.0%
1,1940.0%0.04%
-2.4%
Q4 2017$100,000
+6.4%
1,194
+9.0%
0.04%
+2.4%
Q3 2017$94,000
+3.3%
1,0950.0%0.04%
+2.5%
Q2 2017$91,000
+12.3%
1,0950.0%0.04%
+11.1%
Q1 2017$81,000
-10.0%
1,095
-11.0%
0.04%
-14.3%
Q4 2016$90,000
-18.9%
1,230
-12.8%
0.04%
+10.5%
Q3 2016$111,000
-4.3%
1,4100.0%0.04%0.0%
Q2 2016$116,000
+30.3%
1,410
+14.6%
0.04%
+15.2%
Q1 2016$89,000
-25.2%
1,230
-11.1%
0.03%
-26.7%
Q4 2015$119,000
-6.3%
1,3830.0%0.04%
-10.0%
Q3 2015$127,000
+17.6%
1,383
+26.3%
0.05%
+28.2%
Q2 2015$108,000
+89.5%
1,095
+90.4%
0.04%
+85.7%
Q1 2015$57,000
+7.5%
5750.0%0.02%
+5.0%
Q4 2014$53,000
+178.9%
575
+187.5%
0.02%
+150.0%
Q3 2014$19,000
-40.6%
200
-42.9%
0.01%
-46.7%
Q2 2014$32,000
-58.4%
350
-61.1%
0.02%
-58.3%
Q1 2014$77,000
+28.3%
900
+20.0%
0.04%
+28.6%
Q4 2013$60,000
-13.0%
750
-16.7%
0.03%
-17.6%
Q3 2013$69,000
+3.0%
900
-5.3%
0.03%
+3.0%
Q2 2013$67,0009500.03%
Other shareholders
NOVARTIS A G shareholders Q4 2014
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders